Phosphorylation of the Human La Antigen on Serine 366 Can Regulate Recycling of RNA Polymerase III Transcription Complexes  by Fan, Hao et al.
Cell, Vol. 88, 707–715, March 7, 1997, Copyright 1997 by Cell Press
Phosphorylation of the Human La Antigen
on Serine 366 Can Regulate Recycling of RNA
Polymerase III Transcription Complexes
Hao Fan,* Amy L. Sakulich,* John L. Goodier,* purified fraction. For example, in mammalian systems
TFIIIC2, TFIIIB, and pol III have been highly purified,Xiaolong Zhang,† Jun Qin,† and
while TFIIIC1 and TFIIIC19 represent relatively crude yetRichard J. Maraia*
essential fractions (Wang and Roeder, 1995, 1996).*Laboratory of Molecular Growth Regulation
These results indicate that all the mammalian pol IIINational Institute of Child Health and
TFs have not yet been identified. Likewise, in the yeastHuman Development
system, pure or recombinant TFIIIB and TFIIIC function†Laboratory of Biophysical Chemistry
suboptimally and transcription efficiency is increasedNational Heart, Lung and Blood Institute
by an extract fraction, B99, that contains TFIIIE, or byNational Institutes of Health
the TFIIIE fraction itself (Dieci et al., 1993; Kassavetis etBethesda, Maryland 20892
al., 1995; Ruth et al., 1996). Indeed, TFIIIE is also present
in partially purified IIIB and IIIC fractions and confers its
effect not through assembly of transcription complexesSummary
per se, but through their efficient utilization by pol III
(Dieci et al., 1993).The human La antigen is an RNA-binding protein that
Accumulating evidence indicates that the oligo(dT)
facilitates transcriptional termination and reinitiation
termination signal not only defines the 39 terminus of
by RNA polymerase III. Native La protein fractionates the nascent transcript but also mediates assembly and
into transcriptionally active and inactive forms that are utilization of transcription complexes (Allison and Hall,
unphosphorylated and phosphorylated at serine 366, 1985; Yoshinaga et al., 1987; Kassavetis et al., 1990;
respectively, as determined by enzymatic and mass Chu et al., 1995; Dieci and Sentenac, 1996; Wang and
spectrometric analyses. Serine 366 comprises a ca- Roeder, 1996). Although the composition of TFIIIC in
sein kinase II phosphorylation site that resides within yeast and human appears to differ significantly, a com-
a conserved region in the La proteins from several ponent of TFIIIC binds to the terminator in both systems
species. RNA synthesis from isolated transcription (Kassavetis et al., 1990; reviewed in Wang and Roeder,
complexes is inhibited by casein kinase II-mediated 1996). Terminator-containing but not terminator-lacking
phosphorylation of La serine 366 and is reversible by templates can efficiently recycle a fraction of pol III to
dephosphorylation. This work demonstrates a novel the preinitiation complex by an unknown mechanism
mechanism of transcriptional control at the level of (Dieci and Sentenac, 1996). Mammalian TFIIIC1 binds
recycling of stable transcription complexes. the terminator and mediates assembly of the preinitia-
tion complex, as well as start-site selection by pol III
(Wang and Roeder, 1996). Thus, in yeast and mammalsIntroduction
the terminator is essential for efficient utilization of tran-
scription complexes, although the mechanisms that de-RNA polymerase (pol) III is responsible for synthesizing
termine recycling efficiency remain unclear (Dieci andtRNAs as well as a variety of other small transcripts
Sentenac, 1996; Wang and Roeder, 1996). Understand-(reviewed in Willis, 1993). To accomplish accurate and
ing basic aspects of termination and reinitiation by polefficient RNA synthesis, pol III must rely on transcription
III will require understanding the mechanisms that con-factors (TFs) that bind to the control elements of RNA
trol the factors involved.genes. Adenovirus-associated (VA) RNA and cellular
Human La protein binds to the oligo(U) 39 termini oftRNA genes use internal promoters and 39 terminators,
nascent pol III transcripts and facilitates termination andwhich bind mammalian TFIIIC2 and TFIIIC1, respec-
reinitiation by pol III (Stefano, 1984; Gottlieb and Steitz,tively, to direct transcription by pol III (Yoshinaga et al.,
1989a, 1989b; Maraia et al., 1994; Maraia, 1996). La is
1987; Dean and Berk, 1988; Wang and Roeder, 1996).
a modular protein composed of an N-terminal RNA-
The resulting DNA–protein complex recruits TFIIIB and
binding domain and a phosphoserine-containing C-ter-
subsequently positions pol III for transcription initiation minal domain (Pizer et al., 1983; Francoeur et al., 1985;
(Wang and Roeder, 1996). Although assembly of the Pfeifle et al., 1987; Chang et al., 1994; Kenan, 1995), the
preinitiation complex is rate-limiting for initiation of the latter of which contains a basic region recently shown
first round of RNA synthesis, once formed, the complex to be required for the transcription activity of La (J. L. G.
is stable and can be efficiently reutilized for multiple et al., submitted). Phosphorylation of La therefore repre-
rounds of transcription by pol III (Bogenhagen et al., sents a potential control mechanism for pol III transcrip-
1982; Lassar et al., 1983; Kassavetis et al., 1990; Dieci tion, although the significance and exact site of La phos-
and Sentenac, 1996). phorylation had been unknown.
Despite remarkable progress in understanding the as- Previous studies of the transcription activity of native
sembly of the preinitiation complex, relatively littleatten- La protein were complicated by the fact that HeLa-
tion has been focused on factors that control the recy- derived La purified by heparin and polyU chromatogra-
cling of transcription complexes and pol III (Kovelman phy exhibited little activity, and no distinction was made
and Roeder, 1990; Dieci et al., 1993; Maraia et al., 1994; between phosphorylated and unphosphorylated La pro-
Wang and Roeder, 1995, 1996; Maraia, 1996). With few tein (Gottlieb and Steitz, 1989a, 1989b). Here we show
exceptions, most in vitro transcription assays have used that heparin and polyU chromatography yields a phos-
phorylated form of La that is inactive for transcription,reconstituted systems that contain at least one partially
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and we describe a protocol that yields unphosphory-
lated active La protein. Mass spectrometry and other
methods revealed that inactive La is phosphorylated at
a single site, serine (Ser) 366. The fact that Ser-366 can
be specifically phosphorylated in vitro by casein kinase
II (CKII) has allowed us to investigate the role of phos-
phorylation and dephosphorylation in transcription. La
phosphorylated at Ser-366 binds RNA efficiently but
does not support efficient transcription by pol III. Most
importantly, La phosphoprotein can be reactivated for
transcription by dephosphorylation.
Results
Separation of Transcriptionally Active
and Inactive Forms of La
Although some La antigen was found in each of the
standard P11 phosphocellulose (PC) -A, -B, and -C frac-
tions used for pol III transcription, the majority was in
the PC-A fraction (data not shown). As outlined in Figure
1A, PC-A La can be separated into two forms by
Q-Sepharose chromatography. La that bound Q-Sepha-
rose was purified by heparin, polyU, and DEAE chroma-
tography, and designated U-La (Figure 1A, right). La
that flowed through Q-Sepharose was purified by
S-Sepharose, Reactive blue 4, and mini-S chromatogra-
phy, and designated S-La (Figure 1A, left). Both U-La
and S-La were highly purified, as demonstrated by SDS–
PAGE and Coomassie blue staining (Figure 1B, lanes 5
and 8). U-La and S-La exhibited similar activity in RNA-
binding assays (Figure 1C), indicating that both repre-
sent native active proteins. It is therefore significant that
U-La was inactive for transcription (Figure 1D, lane 3),
while an equivalent amount of S-La was active (Figure
1D, lane 4). S-La (Figure 1D, lane 4) was more active
than recombinant La (rLa) (Figure 1D, lane 2) and re-
mained active in reactions that contained U-La, indicat-
ing that U-La did not contain a general inhibitor of tran-
scription (Figure 1D, lanes 5 and 6).
CKII Copurifies with Inactive La
and Phosphorylates La Ser-366
In a pilot investigation, we found that La purified by a
conventional approach that employed anion exchange,
followed by heparin and polyU chromatography (Ste-
fano, 1984; Gottlieb and Steitz, 1989a, 1989b), contained
a robust activity that phosphorylated rLa. This kinase
activity was subsequently found to copurify with U-La
through the Q and heparin chromatography steps and
to separate from La upon gradient elution from polyU-
Sepharose (data not shown; see Figure 1A). Biochemical
Figure 1. Purification and Characterization of Two Forms of La characteristics of this kinase, which was suspected to
(A) Purification schemes for S-La, U-La, and La kinase (see text) be CKII on the basis of target site preference (below),
from HeLa extract. are shown in lanes 1–12 of Figure 2A. Although the ki-
(B) SDS–PAGE (12%) and Coomassie staining of native La protein
nase could not be inhibited by the CKII-insensitive inhib-at various stages of purification. Identities of the eluted fractions
itors staurosporine, K252b, or DMAP (Figure 2A, lanesas indicated above the lanes correspond to the scheme in (A).
(C) RNA-mediated electrophoretic mobility shift assay (EMSA). Zero
to thirty nanograms of U-La (lanes 1–7) and S-La (lanes 8–14) were
incubated with hY4 32P-RNA and analyzed on 6% native polyacryl- their ability to support VA1 32P-RNA synthesis from isolated tran-
amide gel. Positions of the free RNA and the RNA–protein (RNP) scription complexes. Lanes: 2, recombinant La; 3, U-La; 4, S-La; 5,
are indicated to the right. S-La plus buffer alone; 6, S-La plus U-La. After synthesis, 32P-RNA
(D) Pol III transcription activity of purified La proteins. Preassembled products were purified and analyzed by denaturing PAGE and auto-
immobilized VA1 transcription complexes were employed in a La- radiography. The position of VA1 RNA is indicated to the right.
dependent assay as described (Maraia, 1996). Buffer alone (lane 1) The positions of 32P-labeled markers are indicated to the left in
or 20 pmol of various La preparations (lanes 2–6) were analyzed for nucleotides.
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Figure 3. HeLa-Derived Kinase and rCKII Phosphorylate La on
Ser-366
(A) Ten picomoles of the La protein indicated was incubated with
Figure 2. HeLa-Derived La Kinase Is Casein Kinase II either 3 ml of HeLa-derived La kinase (upper panel) or 0.5 U rCKII
(middle panel) and [32P-g]ATP under standard kinase reaction condi-(A) Characterization of La kinase (lanes 1–12): 3 ml of purified La-
tions, separated by 12% SDS–PAGE, and analyzed by autoradiogra-kinase was incubated with buffer alone (lane 1) or 10 pmol of rLa
phy (upper and middle), or loaded directly and stained with Coomas-(lanes 2–13) in the presence of BSA (lane 2), various kinase inhibitors
sie R-250 (lower). Identities of the constructs are listed above theto which CKII is insensitive (lanes 3–6), or synthetic CKII-specific
lanes and correspond to the span of residues present in that protein.peptide substrate (lanes 7–11). Reactions in lanes 1–11 contained
(B) Alignment of the region around the human La Ser-366 CKII site[32P-g]ATP as phosphate donor while lanes 12 and 13 contained
with the C-terminal domains of La proteins from other species. The[32P-g]GTP. Recombinant (r)CKII (0.5 U) was used in lane 13 as a
CKII consensus sites (S/T)XX(D/E) are underlined (Bairoch et al.,control. Products were analyzed by SDS–PAGE and autoradiog-
1996). Numbers at the left of the sequence correspond to aminoraphy.
acid numbering. Basic residues are shaded red, acidic residues(B) Western blot analysis with anti-CKIIa was used to monitor purifi-
including the predicted phosphorylated residue are shaded yellow,cation of CKII. Identities of the samples are indicated above the
and highly conserved residues are shown in pink. Asterisks indicatelanes and correspond to the purification scheme in Figure 1A; e.g.,
highly conserved residues N-terminal to the CKII site. Numbers tothe polyU lane contains material from the 0.4–0.5 M NaCl fraction
the right indicatenet charge of the regions N-terminal and C-terminaleluted from polyU-Sepharose. The amount of protein from each
to the phosphorylated residue in the potential CKII sites. Full-lengthfraction loaded on the gel is indicated below the lanes.
S. cerevisiae La-homologous protein was aligned with full-length
human La using Bestfit (GCG package, Wisconsin), which aligned
the C-termini as indicated except for the single gap that was intro-3–6), it could be inhibited by two CKII-specific inhibitors,
duced upon alignmemt with Xenopus La. Bestfit alignments of the
heparin (data not shown) and a concentration of peptide two available insect La homologs with human La revealed that both
substrate known to be inhibitory of CKII activity (Km5 terminated within the region compared here and are not shown.
0.5 mM; compare Figure 2A, lanes 10 and 11) (Kuenzel (C) Purified wild-type La S366 and point mutants D366 and G366,
as indicated above the lanes, were incubated with either HeLa-and Krebs, 1985). Another distinguishing feature of CKII
derived La kinase (lanes 1–3) or rCKII (lanes 4–6) and [32P-g]ATPis its ability to use either ATP or GTP as a phosphate
under standard kinase reaction conditions, separated by 12% SDS–donor (Edelman et al., 1987). The HeLa-derived La ki-
PAGE, and analyzed by autoradiography.
nase can use either [32P-g]ATP (Figure 2A, lanes 2–11)
or [32P-g]GTP (Figure 2A, lane 12) as a phosphate donor,
as can rCKII (Figure 2A, lane 13). Although the 0.4–0.5 rCKII (Figure 3A, middle panel) are limited in substrate
recognition to a region between amino acids 364 andM NaCl fraction that eluted from polyU-Sepharose con-
tained many Coomassie blue-staining bands (data not 390 of La. This region contains a CKII phosphorylation
site at Ser-366 as identified by the program PROSITE,shown), Western blotting with anti-CKIIa demonstrated
that this antigen copurified (more than 500-fold) with which searches for the CKII consensus site (S/T)XX
(D/E) (Bairoch et al., 1996).the La kinase activity (Figure 2B).
To identify the region of La phosphylated in vitro, The C-termini of La proteins from several species con-
tain CKII consensus sites, suggesting that this site maywe treated a panel of N- and C-terminal truncated His-
tagged purified La proteins with both HeLa-derived ki- be of physiological significance. The residues around
the potential CKII site also revealed a high degree ofnase and rCKII, and [32P-g]ATP. Figure 3A shows that
the HeLa-derived kinase (Figure 3A, upper panel) and conservation, including basic residues N-terminal to it
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and acidic patches C-terminal to it, as shown in Fig-
ure 3B.
We made substitution mutations in full-length La that
changed Ser-366 to either glycine (La G366) or aspartic
acid (La D366). The His-tagged proteins were purified
using nickel agarose and tested for CKII-substrate activ-
ity (Figure 3C). Wild-type La S366 was readily phosphor-
ylated by HeLa kinase and rCKII (Figure 3C, lanes 1
and 4), while neither La D366 nor La G366 were good
substrates for either kinase (Figure 3C, lanes 2, 3, 5, and
6). Longer exposure of this and other gels revealed that
La D366 and La G366 were labeled at a low level by CKII
(probably due to inefficient phosphorylation of threonine
389; see Discussion). These results demonstrated that
Ser-366 is highly favored over all other potential CKII
sites in La, of which six are predicted by PROSITE (data
not shown).
La is Phosphorylated on Ser-366 In Vivo
S-La was an excellent substrate in our Ser-366-specific
kinase assay (Figure 4A, lane 1), and pretreatment with
phosphatase had little effect on its phosphorylatability
(Figure 4A, lane 2), suggesting that S-La contains a high
Figure 4. Native La Is Phosphorylated on Ser-366content of nonphosphorylated Ser-366. By contrast,
(A) Substrate activity of La proteins. S-La, U-La, and rLa were sub-U-La exhibited very little substrate activity (Figure 4A,
jected to CKII and [32P-g]ATP in either untreated form (lanes 1, 3,lane 3) but could be readily phosphorylated if pretreated
and 5) or after pretreatment with immobilized CIP (lanes 2, 4, and
with phosphatase (Figure 4A, lane 4). By this assay, S-La 6), and subsequently analyzed by 12% SDS–PAGE and autoradiog-
was at least as good a substrate as His-tagged rLa raphy. rLa migrates slower than native La owing to its His-6 tag. A
(compare Figure 4A, lanes 1 and 5). The substrate activ- control mixing experiment is shown in lanes 7–9; U-La alone (lane
7), S-La alone (lane 8), and U-La together with S-La (lane 9) wereity of rLa was not affected by CIP (Figure 4A, lane 6),
assayed as above.suggesting that Ser-366 is not phosphorylated in E. coli.
(B) Vertical slab isoelectric focusing (VSIEF) gel electrophoresis ofA control mixing experiment demonstrated that U-La
various forms of La. Equal amounts (0.35 mg) of U-La (lane 1), S-La
did not inhibit phosphorylation of S-La (Figure 4A, lanes (lane 2), and S-La that was pretreated with CKII and [32P-g]ATP (lane
7–9). Thus, U-La does not contain an inhibitor of the 3) were subjected to VSIEF and Western blotting. Lane 3* shows
an autoradiogram of the nitrocellulose-containing lane 3 that waskinase; rather, the data indicate that U-La is a poor
exposed to X-ray film prior to incubation with the antiserum. Thus,substrate because it is saturated with phosphate on
the bands in lane 3* represent CKII-phosphorylated 32P-La, the sub-Ser-366.
strate of which was native S-La. A control CKII phosphorylation of
La isolated from HeLa cells separates into multiple S-La with nonradioactive ATP produced the same pattern by West-
isoforms (Pizer et al., 1983; Francoeur et al., 1985). We ern analysis as that shown in lanes 3 and 3* (data not shown).
examined La using a one-dimensional vertical slab iso- (C) La protein labeled either in vivo or by CKII in vitro were compared
after digestion with CnBr. The undigested La proteins are shown inelectric focusing (VSIEF) polyacrylamide gel/Western
lanes 1 and 2 and the CnBr-digested proteins are shown in lanes 3blot assay (Figure 4B; Maurides et al., 1989). Both U-La
and 4. Lanes 1 and 3 represent CKII-labeled 32P-La and lanes 2
and S-La focused into multiple bands, some of which and 4 represent in vivo-labeled 32P-La. Positions of size markers
were found in both protein preparations. The distribution coelectrophoresed in the same gel are indicated to the right in
of U-La (Figure 4B, lane 1) was shifted toward the acidic kilodaltons.
end of the gel as compared to S-La. Even in the part of
the gel where there was overlap, S-La and U-La exhib- (CnBr),and resolvedthe fragments by SDS–PAGE. Com-
ited significant differences in the composition of doublet parative analysis revealed that in vivo-labeled La exhib-
bands (Figure 4B, lane 1, arrows). S-La lacked bands ited the same digestion pattern as did S-La phosphory-
present inU-La and contained bands missing from U-La. lated in vitro by rCKII (Figure 4C).
Moreover, the most basic forms of S-La disappeared As a more direct approach toward identifying and
upon treatment with CKII and [32P-g]ATP (Figure 4B, localizing covalent modifications, mass spectrometry
lanes 3 and 3* [see legend]) as they were converted to (MS) was performed on our purified La proteins. In the
more acidic forms found specifically in U-La (Figure 4B, mass spectra of both rCKII-phosphorylated rLa and
compare lanes 1–3). U-La, two peptides with masses of 2406.5 kDa and
It was previously demonstrated by the high resolution 2635.8 kDa, along with many other peptides, were ob-
phosphopeptide mapping approach of Hunter and col- served (Experimental Procedures). These masses corre-
leagues that in vitro phosphorylation of La with CKII spond precisely and specifically to the tryptic fragments
yields the same tryptic phosphopeptide as La labeled La 364–384 and La 362–384, each with one additional
in vivo (Beemon and Hunter, 1978; Pfeifle et al., 1987). phosphate group (calculated masses for these phos-
We labeled HeLa cells with 32P-orthophosphate, immu- phopeptides are 2406.3 kDa and 2635.6 kDa). No pep-
tides corresponding to the unphosphorylated form ofnoprecipitated La, digested it with cyanogen bromide
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these peptides were observed in U-La or CKII-phos-
phorylated rLa. This establishes that La is phosphory-
lated in the region of 364–384 both in vitro by CKII and
in vivo. Since phosphoserine is the only phospho-amino
acid observed in vivo (Pizer et al., 1983; Pfeifle et al.,
1987), and since Ser-366 is the only serine in this region,
we concluded that Ser-366 is the phosphorylation site
in vivo.
The rest of the peptides observed by MS can all be
assigned to other sequences in the La protein, and none
of those were phosphorylated. Thus, we found evidence
for a single phosphorylated peptide in U-La, while the
remaining tryptic peptides (with exception of the N-ter-
minal 16 residues, which were not observed) were de-
tected with no evidence of modification. In contrast to
U-La and as expected, the unphosphorylated peptide
containing Ser-366 was readily detected in S-La. Al-
though a phosphorylated peptide containing Ser-366
was also detectable in S-La, the amount of this relative
to the unphosphorylated peptide cannot be determined
by MS. Therefore, S-La contains a mixture of unphos-
phorylatedandphosphorylated Ser-366-containingpep-
tide, while the rest of the peptides were unmodified
(with the possible exception of the N-terminal 16 residue
peptide, which was not observed). In addition to sup-
porting our conclusion that Ser-366 is phosphorylated
in U-La and unphosphorylated in S-La, MS suggested
that Ser-366 is the only modified residue in La in loga-
rythmically growing HeLa cells (Discussion).
Inhibition and Reactivation of Transcription
by Phosphorylation and
Dephosphorylation of La
Figure 5. Phosphorylation and Dephosphorylation Inhibits and Re-Attempts to detect transcription after dephosphoryla-
activates Lation of U-La were unsuccessful, owing to the potent
(A) Recombinant La proteins (16 pmol each) that were pretreatedinhibitory effects of phosphatase on pol III transcription
with CKII/ATP, CIP, CKII/ATPfollowed by CIP, or mock-treated were(data not shown). Experimental constraints owing to this
used in the pol III transcription assay. Lanes: 1, no La protein added;problem and a limited supply of U-Lawere circumvented
2, untreated La; 3, mock-treated La; 4, CKII/ATP-treated La; 5, CIP-
by using affinity-purified His-tagged La. We treated His- treated La; 6, CKII/ATP treatment followed by CIP. Lane M contains
tagged La singly or sequentially with CKII plus nonradio- denatured markers; sizes in nucleotides are indicated to the left.
activeATP and/or calf intestinal phosphatase (CIP), puri- The position of VA1 32P-RNA is indicated to the right.
(B) Kinetics of phosphorylation-mediated transcription inhibition.fied the products by nickel chromatography, and used
His-tagged La was incubated with rCKII and nonradioactive ATPequal amounts in transcription assays (Figure 5A). Al-
and aliquots were removed at the indicated times and subsequentlythough mock and CIP treatments of La led to some
purified by nickel chromatography. Sixteen picomoles of La from
decrease in transcription (Figure 5A, compare lanes 2, each time point were then incubated with VA1 transcription com-
3, and 5), CKII-phosphorylation inhibited z80% of the plexes and pol III for 45 min in the pol III transcription assay, and
transcription activity of mock-treated La (Figure 5A, VA1 32P-RNA was analyzed as above. Radioactivity counts inthe VA1
32P-RNA bands (inset) were quantitated and plotted as percentagelanes 3 and 4). Most significantly, the inhibition mediated
transcription activity (amount at 0 min 5 100%) against phosphory-by CKII was reversed by CIP treatment (Figure 5A, com-
lation time. Numbers above the lanes in the inset indicate extent ofpare lanes 4 and 6). CIP treatment had little if any effect
phosphorylation reaction in minutes.
on nonphosphorylated La (Figure 5A, compare lanes 3
and 5). Assays that monitored CKII and CIP activities
from aliquots of these reactions revealed that these en- after 4 hr of exposure to CKII and ATP (Figure 5B). We
found that the La products of these CKII reactions couldzymes indeed added and removed 32P as expected (data
not shown). Figure 5A provides direct evidence that be further phosphorylated upon exposure to a subse-
quent CKII reaction that monitored phosphorylatabilityphosphorylation inhibits La activity in the pol III tran-
scription assay (Figure 5A, lane 4),and more importantly, with [32P-g]ATP. As expected, La recovered after short
periods of exposure to the initial CKII reaction could bethat the resulting phosphoprotein can be reactivated by
dephosphorylation (Figure 5A, compare lanes 4 and 6). phosphorylated to a greater extent than La recovered
after longer periods of exposure to CKII (data notWe were unable to inactivate La by phosphorylation
completely, despite several attempts. Kinetic analysis shown). Thus, this analysis demonstrated that both
phosphorylation and transcription inhibition were in-revealed that the transcription activity of La decreased
with CKII treatment but that some activity remained even complete, providing a correlation between the extents
Cell
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allowed the conclusion that La Ser-366 mediates the
inhibitory effects of CKII phosphorylation on pol III tran-
scription.
Efficient recycling occurs when isolated transcription
complexes are supplemented with exogenous La and
pol III (Maraia, 1996). We examined the effects of La
phosphorylation on the kinetics of recycling, and also
examined the La 366 mutants as controls (Figure 6B).
La S366 supported efficient recycling, while CKII-phos-
phorylated La S366 was significantly compromised. In
contrast to the inhibitory effects of CKII on La S366, La
D366 and La G366 were relatively unaffected by CKII
(Figure 6B). Nonphosphorylated and phosphorylated La
S366 bound to RNA efficiently (Figure 6C), indicating
that CKII treatment did not lead to a general inactivation
of La protein. La D366 and La G366 also bound RNA
well (Figure 6C). These data support the important con-
Figure 6. Phosphorylation-Dependent Inhibition of Pol III Transcrip-
clusion made from the results with S-La and U-La thattion Activity of La Is Mediated through Ser-366
the transcriptionactivity of La is not attributable solely to(A) Purified wild-type La S366 and point mutants La D366 and G366
RNA-binding activity. We conclude that phosphorylationwere analyzed for pol III transcription activity after no treatment
of La Ser-366 impairs the ability to support efficient(lanes 1, 4, and 7), CKII/ATP treatment (lanes 2, 5, and 8), and CKII/
ATP treatment followed by CIP treatment (lanes 3, 6, and 9). The recycling of pol III transcription complexes.
upper panel shows VA1 32P-RNA products of in vitro transcription,
and the lower panel shows SDS–PAGE-Coomassie staining of the Discussion
relative amounts of each purified protein used.
(B) Effect of La phosphorylation on kinetics of transcription complex
In this report, we demonstrated that the human La anti-recycling. Six transcription reactions were set up containing La
gen is phosphorylated on Ser-366, and that this modifi-S366, D366, and G366 with and without pretreatment with CKII/
ATP. Aliquots were removed from each reaction at various times cation inhibits the pol III transcription factor activity of
thereafter, and the VA1 32P-RNA products were purified, electropho- La invitro. Ser-366 ispart of a conserved CKII consensus
resed, quantitated (counts 3 1024), and plotted against transcription site that resides in a larger conserved region adjacent
time. Thick solid lines indicate La S366, thin solid lines indicate La to a basic motif that was recently shown to be essential
D366, and dashed lines indicate La G366. All 32P-RNA products were
for the transcription activity of La (J. L. G. et al., submit-generated in parallel reactions and quantitated by PhosphorImager
ted). These results demonstrate that phosphorylationanalysis of the same exposure.
(C) One to thirty nanograms of the La proteins indicated were incu- and dephosphorylation of La can be used to regulate
bated with hY1 32P-RNA and analyzed in parallel on native 6% poly- pol III transcription in vitro, and suggest that this mode
acrylamide gels. Upper left, unphosphorylated La S366; upper right, of regulation may be used in vivo. Specificity of CKII for
CKII-phosphorylated La S366; lower left, La D366; lower right, La
La Ser-366, copurification of CKII and La, and conserva-G366. Positions of free RNA and RNA–protein (RNP) are indicated.
tion of the CKII consensus site suggest that CKII phos-
phorylates La in vivo, although this remains to be deter-
of phosphorylation and inhibition of La activity. In the mined.
next section, we show that the CKII-dependent inhib- The large difference in transcription activity exhibited
itory effect on transcription is mediated through La by S-La and U-La is not attributable solely to RNA bind-
Ser-366. ing, since both proteins exhibit similar RNA-binding ac-
tivity (Figure 1C). The fact that U-La is transcriptionally
The Phosphorylation State of La Ser-366 Controls inactive reconciles the low activity of the La protein
Efficiency of Pol III Transcription previously recovered from HeLa cells by Gottlieb and
Next, we examined La S366, La G366, and La D366 for Steitz (1989b). That study used heparin and polyU chro-
transcription activity before and after phosphorylation matography to purify a fraction equivalent to U-La. It is
by CKII and subsequent dephosphorylation by CIP. The not surprising, therefore, that the La protein used in
La proteins were treated with CKII 1 ATP or CKII 1 ATP those studies exhibited little transcription activity when
then CIP, purified by nickel agarose, and used in the added to anti-La-depleted extract (Gottlieb and Steitz,
pol III transcription assay (Figure 6A). Transcription ac- 1989a, 1989b).
tivity of La S366 (Figure 6A, lane 1) was inhibited by Under certain conditions, La can be hyperphosphory-
phosphorylation (Figure 6A, lane 2). More importantly, lated by CKII to a form that contains phosphothreonine
CKII-phosphorylated La could be reactivated by de- (Pfeifle et al., 1987). This form of electrophoretically re-
phosphorylation with CIP (Figure 6A, lane 3). Compari- tarded La was never observed in native HeLa La from
son of the amounts of La protein used in these reactions any source (data not shown). Using mild conditions,
suggested that G366 exhibits higher activity than S366 CKII-phosphorylated La is nearly indistinguishable from
and D366 (Figure 6A, lower panel, compare lanes 1, 4, in vivo-labeled La in phosphoserine content, SDS–PAGE
and 7). As expected, CKII and CIP treatments had little mobility, and 2D-IEF pattern, the latter of which revealed
effect on the intrinsic activity of La D366 (Figure 6A, a single major phosphopeptide (Pfeifle et al., 1987). Like-
lanes 4–6) and La G366 (Figure 6A, lanes 7–9), which wise, under these conditions, the major CKII-phosphor-
ylated residue is La Ser-366 (Figure 3B).lacked the preferred CKII target site. This experiment
La Phosphoserine 366 Regulates Pol III Transcription
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Transcription inhibition mediated by CKII was not as et al., 1995; McBryant et al., 1996). However, our study
is to be distinguished from these, since we examinedcomplete as that observed for U-La. Although the reason
for this is unknown, the following two points should be the utilization of preassembled transcriptioncomplexes,
not their assembly. The cumulative data indicate thatconsidered. Data not shown revealed that La phosphor-
ylated with nonradioactive ATP and used for transcrip- utilization of transcription complexes can be regulated
independently of assembly. Phosphorylation and de-tion assays was a better substrate in analytical CKII
assays that employed radioactive ATP than was U-La phosphorylation of La can afford the cell the ability to
regulate RNA synthesis without having to disassemble(data not shown; see text above describing Figure 5B).
This suggests that CKII-phosphorylated La is hypophos- and reassemble entire transcription complexes.
Yeast pol III has been shown to undergo facilitatedphorylated relative to U-La. Thus, although MS detected
no unphosphorylated peptide in CKII-phosphorylated recycling on the same template (Dieci and Sentenac,
1996). Limiting amounts of mammalian pol III are recy-La, the analytical kinase assay appears tobe more sensi-
tive to the phosphorylation state of La Ser-366 than is cled onto stable transcription complexes at least 5-fold
more efficiently in the presence of La than in its absenceMS, and provides both evidence that CKII-phosphory-
lated La is indeed hypophosphorylated relative to U-La (Maraia et al., 1994). A role for La in clearing the template
of both newly synthesized RNA and polymerase that isand an explanation for why CKII-phosphorylated La is
more active than U-La. In addition, phosphorylation of paused at the terminator would be expected to increase
pol III recycling (Gottlieb and Steitz, 1989a, 1989b). Al-Ser-366 by CKII in vitro is accompanied by partial phos-
phorylation of sites that are not phosphorylated in U-La. though recent evidence suggests that La may also be
capable of directing pol III to the preinitiation complex,Analyses not shown, including direct detection by MS,
indicate that a fraction of CKII-phosphorylated La is it is unknown whether La is involved in facilitated recy-
cling as described for yeast pol III (Maraia, 1996). Yeastphosphorylated on threonine 389. It is therefore plausi-
ble that phosphothreonine 389 partially abrogates the TFIIIE appears to function somewhat analogously to La,
since it increases the utilization of stable preinitiationnegative influence of phosphoserine 366. We wish to
emphasize, however, that threonine phosphorylation complexes (Dieci et al., 1993; also, see Kassavetis et
al., 1995; Ruth et al., 1996). Whether TFIIIE contains adoes not occur in vivo and therefore appears to be due
to an in vitro artifact of CKII (Pizer et al., 1983; Pfeifle La homologous protein (lhp1) must await further charac-
terization. Unlike other pol III transcription factors, lhp1et al., 1987). We could nonetheless demonstrate the
specific inhibitory effects of phosphoserine 366 with the is dispensable in S. cerevisiae, suggesting that La plays
a regulatory rather than an essential role in RNA biogen-mutants La D366 and La G366 (Figure 6).
Although a phosphate-containing peptide was detect- esis in yeast and/or that another protein can substitute
for lhp1 in this function (Yoo and Wolin, 1994). It willable in S-La by MS, the fraction of phosphorylated pep-
tide can not be determined by this method. Our Ser- therefore be of interest to determine if lhp1 and/or TFIIIE
is phosphorylated in yeast and, if so, under what condi-366-specific assay indicates that the great majority of
S-La is unphosphorylated at this residue (Figure 4A). In tions this modification can regulate pol III transcription.
In any case, it seems that high levels of pol III transcrip-any case, S-La contains basic forms that are not present
in U-La, and the presence of these correlates with tran- tion in yeast and mammals requires efficient reinitiation
at preassembled initiation complexes, and in both sys-scriptional activity. Likewise, U-La contains no unphos-
phorylated La and this accounts for its lack of transcrip- tems, specific factors appear to be involved in control-
ling the efficiency of reinitiation.tional activity.
Recombinant La resolves into nearly as many IEF
bands as native HeLa La, arguing that La exhibits intrin- Experimental Procedures
sic propensity for charge heterogeneity. Treatment of
Antibodies, Enzymes, and PeptidesHeLa La with CIP shifts the most acidic of eight bands
Human recombinant (r)CKII was obtained from Calbiochem (La Jolla,to four basic bands while reducing the doublet band
CA); soluble calf intestinal phosphatase (CIP) was from Boehringer
pattern to singlets (data not shown). Phosphorylation Mannheim (Indianapolis, IN); immobilized CIP was from Sigma (St.
under conditions that label Ser-366 specifically pro- Louis, MO); CKII peptide substrate RRRDDDTDDD was from
duces multiple 32P-labeled bands (Figure 4B, lane 3*). GIBCO–BRL (Rockville, MD); anti-CKIIa was from Upstate Biotech,
Inc.; and anti-La was from the Centers for Disease Control (Atlanta,Thus, it appears that phosphorylation on a single site
GA). Pol III was purified from HeLa extract as described with minorcan lead to multiple phosphorylated forms of La. Phos-
modifications (Sklar and Roeder, 1976).phorylation of Ser-366 can account for most if not all of
the La phosphorylation in vivo.
Fractionation of HeLa ExtractSome transcription factors are activated and some
HeLa-S3 cells were grown in suspension in Joklik’s MEM. One hun-
are inactivated by CKII (for example, see Lin et al., 1992; dred twenty liters of cells (1.2 3 1011) yielded 700 ml of whole cell
Voit et al., 1992). Loss of CKII activity has been reported extract (equivalent to S-100 plus nuclear extract); this was loaded
to lead to decreased transcription by yeast pol III (Hock- onto a 500 ml phosphocellulose(Whatman, P11) column equilibrated
with buffer A (20 mM HEPES [pH 7.9], 20% glycerol, 0.2 mM EDTA,man and Schultz, 1996). Although the target of CKII was
0.5 mM DTT, 0.5 mM PMSF) containing 0.1 M KCl. Purification ofnot identified in that study, it was suggested that it was
La was monitored by following La antigen in Western blots. Materialmost likely required for the assembly of yeast pol III
that flowed through P11 (PC-A) was used for purification of the two
transcription complexes and/or initiation (Hockman and forms of La. Five hundred milliliters of PC-A was loaded onto a 270
Schultz, 1996). Indeed, phosphorylation of TFs appears ml Q-Sepharose Fast Flow (Pharmacia) column, and the flowthrough
to be a mechanism to control the assembly of pol III was routed to a 125 ml S-Sepharose Fast Flow (Pharmacia) column.
La that flowed through Q-Sepharose was not due to overloadingtranscription complexes (Gottesfeld et al., 1994; White
Cell
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the Q column (data not shown). Both Q and S columns werepreequil- and analyzed by electrophoresis on 6% native polyacrylamide gels,
followed by autoradiography.ibrated with La buffer (LB; 25 mM Tris-Cl [pH 8.0], 20% glycerol,
0.1 mM EDTA, 0.5 mM DTT) containing 0.1 M NaCl. A linear gradient
of LB containing 0.1 to 1.0 M NaCl eluted the Q column; La eluted Peptide Mapping
between 0.33 and 0.55 M NaCl and was loaded directly onto a 25 HeLa cells were incubated with 32P-orthophosphate for 10 hr (Pizer
ml Heparin-Sepharose (Pharmacia) column, and a linear gradient of et al., 1983). Cell monolayers were washed with PBS and whole cell
0.4–2.5 M NaCl in LB was applied. La eluted from Heparin-Sepha- extract was prepared. Recombinant La labeled in vitro with 32P by
rose between 0.8 and 1.2 M NaCl, and was dialyzed and loaded CKII and the in vivo 32P-labeled extract were immunoprecipitated
onto a 16 ml polyU-Sepharose (Pharmacia) column. After washing, with anti-La IgG immobilized on protein A-Sepharose (Pharmacia).
a lineargradient of 0.1–2.5 MNaCl was applied and La kinase activity The immunoprecipitates were treated with RNase to degrade la-
(monitored as described below) eluted between 0.4 and 0.5 mM beled RNA. The z50 kDa 32P-La bands were readily identified by
NaCl. After washing with 2.5 M NaCl in LB, La antigen was step SDS–PAGE and excised, and the gel slices containing the bands
eluted from polyU-Sepharose with 4 M NaCl in LB. After desalting, were crushed, equilibrated with 70% formic acid, subjected to 50
this was loaded on a 2 ml DEAE-Cellulose 52 (Whatman) column to mg/ml of CnBr (Sigma) in 70% formic acid, and analyzed by SDS–
remove polynucleotides that leeched off the polyU column (data not PAGE (10%–27% polyacrylamide) (Barsh and Byers, 1981).
shown).
La that flowed through Q-Sepharose bound to S-Sepharose with La-Dependent Pol III Transcription
no change of buffer and eluted between 0.3–0.45 M NaCl in LB. La Preinitiation complexes preassembled on the VA1 RNA gene were
was then bound to a Reactive blue 4 Sepharose (Sigma) column and isolated as described and aliquotted to multiple tubes (Maraia,
eluted between 1.1 and 1.7 M NaCl. This solution was concentrated, 1996). Pol III (20 U) and La (16 pmol) were added in a total volume
desalted, and bound to a Mini-S column (Smart system, Pharmacia), of 25 ml and incubated for 45 min, or these reactions were scaled
and eluted between 0.25 and 0.35 M NaCl. RNA contamination, as up and aliquots were removed at various times, and RNA prepared.
monitored by spectrophotometric scanning at 260/280 nm, revealed Quantitation was performed using a PhosphorImager equipped with
that U- and S-La were indistinguishable and contained little if any ImageQuant software (Molecular Dynamics).
nucleic acid (data not shown).
Vertical Slab Isoelectric Focusing and Western Blotting
Recombinant La Proteins The procedure described by Maurides et al. (1989) was used with
cDNAs encoding wild-type or truncated La followed by a His-6 tag slight modifications. Pharmalytes (pH 5–8 and pH 3–10) (1:1, Phar-
were expressed in pET28a (Novagen). La D366 and La G366 were macia) were used at a concentration of 6% in the gel and 2% in the
generated by oligonucleotide-mediated mutagenesis using full- overlay and sample buffers. A 17 cm 3 1 mm gel was electropho-
length His-La cDNA as template. Purification was achieved by resed for21 hr at 2.5 mA with a 1000 V limit. A DSG-200 electrophore-
nickel-affinity resin according to the manufacturer’s instructions (Qi- sis unit (CBS Scientific, Del Mar, CA) was used with a circulating
agen), and for Las S366, D366, and G366 this was followed by pump set at 178C. The upper reservoir contained the anode and
S-Sepharose chromatography. Concentrations of La proteins were 0.01 N phosphoric acid, and the lower chamber contained the cath-
determined by comparison to a standard La (generous gift of D. ode and 0.02 M NaOH. The VSIEF gel was electroblotted to Protran
Kenan, Duke University) following SDS–PAGE and Coomassie nitrocellulose (Schleicher and Scheull, Keene, NH) in 13 Tris–
staining. glycine–SDS buffer (Biorad) containing 20% methanol at 100 V for
1.5 hr at 108C. The blot was incubated with anti-La and processed
using 125I-protein A (Amersham).Standard Kinase Assay
In vitro analytical kinase assays were performed in 10 ml reactions
containing a premixed pool of 0.2 mM ATP, [32P-g]ATP (NEN, 3000 Mass Spectrometry
Ci/mmol; equivalent to 0.2 ml per reaction), 10 mM MgCl2, 10 mM A matrix-assisted laser desorption/ionization time-of-flight mass
Tris-Cl (pH 7.5), 1–3 ml of each HeLa fraction to be assayed de- spectrometer (Chait and Kent, 1992) (model Voyager-DE, PerSeptive
pending on the stage of purity, or rCKII, and 10 pmol of La protein. Biosystems, Framingham, MA) was used. One hundred nanograms
After 45 min at 308C, reactions were stopped by addition of 10 ml of sequencing–grade modified trypsin (Boehringer Mannheim) was
of 23 SDS-loading buffer, heated to 1008C for 3 min, and analyzed added to 10 ml of rLa or rCKII-phosphorylated rLa, both at 0.12 mg/
by 12% SDS–PAGE and autoradiography. For the kinase assay ml in 20 mM HEPES (pH 7.9), 20% glycerol, and 0.2 M NaCl. This
shown in Figure 4A, U-La, S-La, and rLa were incubated with 2 U was incubated at 378C for 2 hr, after which an equal volume of
of prewashed agarose-immobilized CIP in a 40 ml reaction at 378C acetonitrile was added. One microliter of the resulting mixture was
for 60 min. CIP-agarose was removed by microfiltration and the combined with 1 ml of working matrix solution (2-fold dilution of 2,5-
soluble La proteins were recovered and used in the kinase assay. dihydroxybenzoic acid in 1:1 water:acetonitrile) on the sample plate
of the spectrometer. The sample plate was dried in ambient air,
inserted into the spectrometer, and an MS spectrum of the trypticPhosphorylation and Dephosphorylation of rLa
peptide mixture was obtained. Similar trypsin digestions were car-with CKII and CIP
ried out using 5 ml of U-La (0.25 mg/ml in LB containing 0.2 M NaCl)Preparative in vitro phosphorylation was performed in 200 ml reac-
with 100 ng of trypsin and 5 ml of 50 mM ammonium bicarbonatetions containing 20 mg of His-tagged La S366, D366, or G366, 500
(pH 8). One microliter of S-La (0.8 mg/ml in LB containing 0.4 M NaCl)U of rCKII, 0.2 mM ATP, 10 mM MgCl2, 50 mM NaCl, and 20 mM
was digested with 50 ng of trypsin and 3 ml of 50 mM ammoniumTris-Cl (pH 7.5). After incubation at 308C for 2 hr, the His-tagged
bicarbonate. The MS spectra of the resulting tryptic peptides areproteins were purified by nickel agarose and washed. Seventy-five
described in the text.units of soluble CIP or buffer alone was then added and the mixture
incubated an additional 3 hr. After removal of CIP and extensive
washing, La proteins were eluted from the nickel agarose, dialyzed, Acknowledgments
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